Bicalutamide -Teva 50mg №28

Use Bicalutamide-Teva is used to treat prostate cancer as part of combination therapy with a gonadotropin-releasing hormone (GnRH) analog or with surgical castration. How to take For advanced prostate cancer in combination with a GnRH analog or surgical castration, the drug is taken orally at 50 mg once a day. Treatment with Bicalutamide-Teva should be started simultaneously with the initiation of GnRH analog therapy or surgical castration. For locally advanced prostate cancer, the drug is taken orally at 150 mg once a day. The drug should be taken long-term, for at least 2 years. If signs of disease progression appear, the drug should be discontinued. Contraindications - Hypersensitivity to bicalutamide or other excipients of the drug. - Concomitant use with terfenadine, astemizole, and cisapride. - The drug should not be prescribed to children and women. - Lactose intolerance, lactase deficiency, or glucose-galactose malabsorption.